Trade RLMD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Relmada Therapeutics, Inc. (RLMD) is trading at US$4.33, down 4.20% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$493.88M. Over the past 52 weeks, RLMD has traded between US$1.06 and US$8.00. On Syfe you can trade RLMD with $0 commission and add it to your watchlist.
| Previous close | US$4.52 |
|---|---|
| Market cap | US$493.88M |
| 52-week range | US$1.06 – US$8.00 |
| Volume | 678.36K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. engages in the development of clinical-stage drugs. The firm's pipeline includes NDV-01 and Sepranolone. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
Year: 2014
Relmada Therapeutics Joins Russell 2000, Russell 3000 Indexes
Jun 29, 6:55 PM · MT Newswires
HC Wainwright Initiates Relmada Therapeutics at Buy With $12 Price Target
Jun 18, 10:46 AM · MT Newswires
Relmada Therapeutics Q1 Loss per Share Narrows
May 12, 8:35 PM · MT Newswires
--Earnings Flash (RLMD) Relmada Therapeutics Posts Q1 Loss $0.22, vs. FactSet Est of $0.20 Loss
May 12, 8:21 PM · MT Newswires
--Piper Sandler Initiates Coverage on Relmada Therapeutics With Overweight Rating
Mar 24, 11:58 AM · MT Newswires
Relmada Therapeutics, Inc. (RLMD) stock is trading at US$4.33, -4.20% from the previous close of US$4.52.
The market cap for Relmada Therapeutics, Inc. (RLMD) stock is approximately US$493.88M.
The 52-week high for Relmada Therapeutics, Inc. (RLMD) stock is US$8.00.
The 52-week low for Relmada Therapeutics, Inc. (RLMD) stock is US$1.06.
Relmada Therapeutics, Inc. (RLMD) does not currently pay a dividend.
Stay on top of RLMD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
